CTC Alternative Strategies »

SPDR S&P Biotech shares owned by CTC Alternative Strategies

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by CTC Alternative Strategies from 13F filings

Historical chart of CTC Alternative Strategies investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by CTC Alternative Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by CTC Alternative Strategies

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 13k 92.71
2023-06-30 $237k 2.9k 83.20

More positions owned by CTC Alternative Strategies

Ishares Tr Iboxx Inv Cp Etf (LQD)
Southwestern Energy Company
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Communication (XLC)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Sbi Materials (XLB)
Select Sector Spdr Tr Energy (XLE)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Costco Wholesale Corporation (COST)
Procter & Gamble Company (PG)
Select Sector Spdr Tr Financial (XLF)
Spotify Technology S A SHS (SPOT)
Chevron Corporation (CVX)

View all positions for CTC Alternative Strategies

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech